Shareholders' Equity (Details) - USD ($)	1 Months Ended			12 Months Ended
	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Stock Repurchase Program [Abstract]
Stock repurchase program, additional amount authorized		$ 2,000,000
Stock repurchase program authorized amount	$ 22,000,000			$ 22,000,000
Stock repurchased during period (in shares)				24,308
Amount paid to repurchase shares during the year				$ 685,808	$ 537,379
Amount of common stock repurchased	$ 19,309,437			$ 19,309,437
Number of common stock acquired (in shares)	1,326,213			1,326,213
Earnings Per Share [Abstract]
Basic weighted average shares outstanding (in shares)				3,167,719	3,171,919
Weighted average dilutive options outstanding (in shares)				0	0
Diluted weighted average shares outstanding (in shares)				3,167,719	3,171,919
Statutory Restrictions [Abstract]
Minimum statutory surplus required to maintain	$ 2,500,000			$ 2,500,000
Period from declaration of ordinary dividend requires notification to insurance commissioner				5 days
Minimum period prior to payment of dividend requires notification to insurance commissioner				10 days
Percentage of statutory capital and surplus	10.00%			10.00%
Ordinary dividends paid				$ 3,000,000	$ 5,000,000
Period for which no extraordinary dividends paid				2 years
Outside Directors [Member]
Share-based Compensation [Abstract]
Annual retainer fee paid to director				$ 5,000
Per meeting fee paid to director				$ 2,500
Number of shares issued (in shares)	4,485		4,269
Stock issued during period (in dollars per share)	$ 25.06		$ 27.5	$ 25.06	$ 27.5
Cost of shares issued				$ 112,394	$ 117,398
Management and Employees [Member]
Share-based Compensation [Abstract]
Number of shares issued (in shares)				17,963	6,294
Cost of shares issued				$ 486,798	$ 170,537